ORG Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Buy
81,054
+9,122
+13% +$239K 0.29% 45
2026
Q1
$2.02M Buy
71,932
+9,679
+16% +$258K 0.4% 40
2025
Q4
$1.55M Sell
62,253
-1,349
-2% -$34K 0.36% 46
2025
Q3
$1.62M Sell
63,602
-14
-0% -$346 0.34% 44
2025
Q2
$1.59M Buy
63,616
+4,390
+7% +$102K 0.38% 37
2025
Q1
$1.45M Buy
59,226
+57,112
+2,702% +$1.49M 0.45% 40
2024
Q4
$56.1K Sell
2,114
-1,847
-47% -$50.1K 0.02% 244
2024
Q3
$115K Buy
+3,961
New +$116K 0.04% 170

Other funds holding PFE

ORG Wealth Partners's PFE Position: Q2 2026 in Review

ORG Wealth Partners increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $239K and bringing the position to 81,054 shares worth $1.95M. The position accounts for 0.29% of the portfolio, ranked #45.

ORG Wealth Partners first reported a position in PFE in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.02M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • ORG Wealth Partners held 81,054 shares of Pfizer worth $1.95M as of Q2 2026.
  • ORG Wealth Partners bought 9,122 Pfizer shares in Q2 2026, an estimated $239K.
  • Pfizer made up 0.29% of ORG Wealth Partners's portfolio in Q2 2026, its #45 holding.
  • ORG Wealth Partners first reported a position in Pfizer in Q3 2024 and has held it in 8 quarters since.
  • ORG Wealth Partners's Pfizer position peaked at $2.02M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.